IMPETIGO - AN OVERVIEW

被引:66
作者
DARMSTADT, GL
LANE, AT
机构
[1] Department of Dermatology, Stanford University School of Medicine, Stanford, California
关键词
D O I
10.1111/j.1525-1470.1994.tb00092.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
This article reviews in detail the pathogenesis, clinical characteristics and management of impetigo in children. Impetigo is the most common bacterial skin infection of children. Most cases of nonbullous impetigo and all cases of bullous impetigo are caused by Staphylococcus aureus. The remainder of cases of nonbullous impetigo are due to group A beta hemolytic streptococci (GABHS). GABHS colonize the skin directly by binding to sites on fibronectin that are exposed by trauma. In contrast, S. aureus colonizes the nasal epithelium first; from this reservoir, colonization of the skin occurs. Patients with recurrent impetigo should be evaluated for carriage of S. aureus. Superficial, localized impetigo may be treated successfully in more than 90% of cases with topical application of mupirocin ointment. Impetigo that is widespread or involves deeper tissues should be treated with a beta-lactamase-resistant oral antibiotic. The choice of antibiotics is affected by the local prevalance of resistance to erythromycin among strains of S. aureus, antibiotic cost and availability, and issues of compliance.
引用
收藏
页码:293 / 303
页数:11
相关论文
共 93 条
[71]  
Aly R, Shinefield HR, Litz C, Maibach HI., Role of teichoic acid in the binding of Staphylococcus aureus to nasal epithelial cells, J Infect Dis, 141, pp. 463-465, (1980)
[72]  
Guinan ME, Dan BB, Guidotti RJ, Et al., Vaginal colonization with Staphylococcus aureus in healthy women: a review of four studies, Ann Intern Med, 96, pp. 944-947, (1982)
[73]  
Dancer SJ, Noble WC., Nasal, axillary, and perineal carriage of Staphylococcus aureus among women: identification of strains producing epidermolytic toxin, J Clin Pathol, 44, pp. 681-684, (1991)
[74]  
Casewell MW, Hill RLR., Elimination of nasal carriage of Staphylococcus aureus with mupirocin (‘pseudomonic acid’)a controlled trial, J Antimicro Chemo, 17, pp. 365-372, (1986)
[75]  
Martin RR, White A., The reaquisition of staphylococci by treated carriers: a demonstration of bacterial interference, J Lab Clin Med, 71, pp. 791-797, (1968)
[76]  
Doebbeling BN, Breneman DL, Neu HC, Et al., Elimination of Staphylococcus aureus nasal carriage in health care workers: analysis of six clinical trials with calcium mupirocin ointment, Clin Infect Dis, 17, pp. 466-474, (1993)
[77]  
Kauffman CA, Terpenning MS, Xiaogong H, Et al., Attempts to erradicate methicillin‐resistant Staphylococcus aureus from a long‐term‐care facility with the use of mupirocin ointment, Am J Med, 94, pp. 371-378, (1993)
[78]  
Dacre JE, Emmerson AM, Jenner GA., Nasal carriage of gentamycin and methicillin‐resistant Staphylococcus aureus treated with topical pseudomonicacid, Lancet, 2, (1983)
[79]  
Dhar S, Kanwar AJ, Kaur S, Sharma P, Ganguly NK., Role of bacterial flora in the pathogenesis and management of atopic dermatitis, Indian J Med Res, 95, pp. 234-238, (1992)
[80]  
Boelaert JR, De Smedt RA, De Baere YA, Et al., The influence of calcium mupirocin nasal ointment on the incidence of Staphylococcus aureus infections in haemodialysis patients, Nephrol Dial Transplant, 4, pp. 278-281, (1989)